Global Nuclear Medicine Equipment Market Size Study & Forecast, by Product Type (SPECT, PET, Planar Scintigraphy) and Application (Cardiology, Oncology, Neurology, General Imaging) and Regional Forecasts 2025-2035

The Global Nuclear Medicine Equipment Market is valued at approximately USD 2.76 billion in 2024 and is projected to expand at a robust CAGR of 6.70% over the forecast period from 2025 to 2035. Nuclear medicine equipment, encompassing modalities such as Single Photon-Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and Planar Scintigraphy, plays a pivotal role in diagnostic imaging by providing high-precision insights into physiological and biochemical processes. These systems are indispensable for accurate diagnosis, treatment monitoring, and therapeutic planning across multiple clinical domains, including cardiology, oncology, and neurology. The market’s growth is propelled by increasing prevalence of chronic and lifestyle-related diseases, rising demand for early and precise diagnostic tools, and continuous technological innovations in imaging modalities.

The surging adoption of advanced nuclear medicine systems is driven by healthcare providers’ pursuit of improved patient outcomes and operational efficiency. PET and SPECT imaging technologies, in particular, are witnessing heightened utilization due to their unparalleled ability to visualize molecular and functional changes before structural anomalies occur. According to the World Health Organization, cardiovascular diseases and cancer remain the leading causes of morbidity globally, emphasizing the necessity for advanced diagnostic imaging solutions. Furthermore, research and development investments in radiopharmaceuticals, hybrid imaging systems, and AI-assisted imaging analytics are opening new avenues for enhanced diagnostic accuracy. Nevertheless, challenges such as high equipment costs, stringent regulatory approvals, and limited access in developing regions may moderately restrain market growth during the forecast period.

Regionally, North America commands the largest share of the Nuclear Medicine Equipment Market, underpinned by its well-established healthcare infrastructure, widespread adoption of cutting-edge imaging technologies, and substantial investment in clinical research and diagnostic imaging. Europe holds a significant market presence owing to government initiatives supporting cancer and cardiovascular disease management, as well as strong reimbursement frameworks. The Asia Pacific region is anticipated to register the fastest growth trajectory, fueled by rising healthcare expenditure, burgeoning geriatric populations, expanding hospital networks, and increasing penetration of nuclear medicine technologies in countries like China and India. Latin America and the Middle East & Africa are projected to demonstrate steady growth, driven by infrastructural development, increased awareness of nuclear diagnostic procedures, and gradual expansion of healthcare access.

Major market players included in this report are:
• GE Healthcare
• Siemens Healthineers
• Canon Medical Systems Corporation
• Philips Healthcare
• Toshiba Medical Systems Corporation
• Spectrum Dynamics Medical
• Mediso Medical Imaging Systems
• Hermes Medical Solutions
• Hyperfine Research
• Positron Corporation
• Sedecal
• Cardinal Health
• Neusoft Medical Systems
• ACIST Medical Systems
• PMI Medical Imaging

Global Nuclear Medicine Equipment Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product Type:
• Single Photon-Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Planar Scintigraphy

By Application:
• Cardiology
• Oncology
• Neurology
• General Imaging
• Others

By End User:
• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more